Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita

Nishio N, Takahashi Y, Ohashi H, Doisaki S, Muramatsu H, Hama A, Shimada A, Yagasaki H, Kojima S. Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita.
Pediatr Transplantation 2011: 15:161–166. © 2010 John Wiley & Sons A/S.

[1]  J. Tolar,et al.  Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita , 2011, Bone Marrow Transplantation.

[2]  B. Alter,et al.  Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.

[3]  F. Locatelli,et al.  Bone marrow transplantation for inherited bone marrow failure syndromes. , 2010, Pediatric clinics of North America.

[4]  A. Yoshimi,et al.  Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children , 2009, Pediatric transplantation.

[5]  P. Rosenberg,et al.  Cancer in dyskeratosis congenita. , 2009, Blood.

[6]  I. Dokal,et al.  Advances in the understanding of dyskeratosis congenita , 2009, British journal of haematology.

[7]  J. Wagner,et al.  HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  T. Smolarek,et al.  Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman–Diamond syndrome , 2008, Bone Marrow Transplantation.

[9]  T. Vulliamy,et al.  Inherited aplastic anaemias/bone marrow failure syndromes. , 2008, Blood reviews.

[10]  P. Pagel,et al.  Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  J. de la Fuente,et al.  Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantation , 2007, Pediatric transplantation.

[12]  M. Ayas,et al.  Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low‐dose cyclophosphamide and anti‐thymocyte globulin , 2007, Pediatric blood & cancer.

[13]  S. Kojima,et al.  Mutations in telomerase catalytic protein in Japanese children with aplastic anemia. , 2006, Haematologica.

[14]  J. Fournet,et al.  Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen , 2005, Bone Marrow Transplantation.

[15]  F. Locatelli,et al.  Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party , 2005, Bone Marrow Transplantation.

[16]  M. Ostronoff,et al.  Successful nonmyeloablative bone marrow transplantation in a corticosteroid-resistant infant with Diamond–Blackfan anemia , 2004, Bone Marrow Transplantation.

[17]  C. Schmidt,et al.  Marrow transplantation for pancytopenia in dyskeratosis congenita , 1985, Blut.

[18]  Y. Dror,et al.  Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita , 2003, Bone Marrow Transplantation.

[19]  R. Storb,et al.  Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita , 2003, Bone Marrow Transplantation.

[20]  C. Schmoor,et al.  Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  S. Perrotta,et al.  Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine‐based reduced‐intensity conditioning regimen , 2002, British journal of haematology.

[22]  K. Horibe,et al.  Prospective monitoring of the Epstein–Barr virus DNA by a real‐time quantitative polymerase chain reaction after allogenic stem cell transplantation , 2001, British journal of haematology.

[23]  T. Ekman,et al.  The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning , 2001, Bone Marrow Transplantation.

[24]  M. Kletzel,et al.  Hematopoietic stem‐cell transplantation using unrelated cord‐blood versus matched sibling marrow in pediatric bone marrow failure syndrome: One center’s experience , 1999, Pediatric transplantation.

[25]  Yun-Fai Chris Lau,et al.  BONE MARROW TRANSPLANT FOR DYSKERATOSIS CONGENITA , 1999, British journal of haematology.

[26]  G. Ghahremani,et al.  Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation , 1999, Bone Marrow Transplantation.

[27]  H. Esperou,et al.  Unusual complications after bone marrow transplantation for dyskeratosis congenita , 1998, British journal of haematology.

[28]  T. Shimizu,et al.  Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation , 1997, Bone Marrow Transplantation.

[29]  H. Deeg,et al.  Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita , 1996, British journal of haematology.

[30]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[31]  L. Luzzatto,et al.  Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. , 1992, Blood.

[32]  C. Loirat,et al.  Case Reports LATE VASCULAR COMPLICATIONS AFTER BONE MARROW TRANSPLANTATION FOR DYSKERATOSIS CONGENITA , 1991, British journal of haematology.

[33]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.